Open AccessMinimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study
Author(s) -
Megan E. B. Clowse,
Frauke Förger,
Caroline Hwang,
John Thorp,
Radboud J. E. M. Dolhain,
Astrid van Tubergen,
Laura Shaughnessy,
Jeff Simpson,
Marie Teil,
Nathalie Toublanc,
Maggie Haitian Wang,
Thomas W. Hale
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/hhyp-7t13
Subject(s) - certolizumab pegol , pharmacokinetics , medicine , postmarketing surveillance , medical physics , pharmacology , adverse effect , rheumatoid arthritis , etanercept
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom